Kidney Carcinoma — Trials

Kidney Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,681 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 398
Recruiting: 202
Ph III recruiting: 17
Growth YoY: +1.2%
Industry share: 32%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 39.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (283)

clinicaltrialsPublishedShowing 51–57 of 57 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05128487	A Study of NDI 1150-101 in Patients With Solid Tumors	active not recruiting	Phase 1 / Phase 2	106	Nimbus Saturn, Inc.INDUSTRY	1	Nov 25, 2024	clinicaltrials
NCT03845166	A Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors(STELLAR-001)	active not recruiting	Phase 1	325	ExelixisINDUSTRY	10	Nov 19, 2024	clinicaltrials